OUMAR SANO: Open Payments
NPI 1770912123 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 15 payments from 9 companies in 2025. Trend: 2023 $1,002 · 2024 $1,264 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $303 |
| Novo Nordisk Inc | 4 | $104 |
| Vanda Pharmaceuticals Inc. | 1 | $101 |
| Alkermes, Inc. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Indivior Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Medtronic, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: COBENFY, FANAPT, Ozempic, VIVITROL, Rybelsus, JARDIANCE, SUBLOCADE, BEXSERO.
Industry payments across PA — which companies pay providers there.
